세계의 글리코믹스 시장 규모 조사 및 예측 : 제품별, 용도별, 최종 용도별, 지역별 분석(2023-2030년)

Global Glycomics Market is valued at approximately USD 1.65 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2023-2030. Glycomics is the study of glycans, which are saccharides found in all living organisms. The field is focused on understanding their structure, biology, and function, and has gained interest in disease profiling and biological processes. However, the high cost of tools used in glycomics research hinder market growth.

Technological advancements in glycomics instruments have been a major factor driving the global market, along with increasing investments from governments and biotech companies. For example, in July 2020, GlycoNet, received funding of USD 16.3 million to support their research efforts in glycomic research. Moreover, the study of glycomics in disease profiling and biological processes has become increasingly popular, leading to a significant increase in research and development activities in this area. Recently, the Canadian Glycomics Network and BridgeBio Pharma, Inc. joined forces in April 2021 to apply scientific research in glycomics to develop treatments for patients with genetic diseases. However, the complexity and diversity of glycans make their analysis and characterization challenging for the market to propel. Despite all the challenges, the growing number of biotechnology and biopharmaceutical companies can offer opportunities in the glycomics market.

The key regions considered for the Global Glycomics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to increasing research and development activities and government funding programs. Companies are investing in research and development activities, which are expected to propel the growth of glycomics in the region. According to a report by Statista, in 2022, the research and development (R&D) expenditure by some pharmaceutical companies reached around 101 billion U.S. dollars worldwide. Europe is expected to grow significantly over the forecast period. Due to factors such as research infrastructure with the presence of world-class universities and research institutes. In addition, the availability of funding programs and grants for research has allowed biopharmaceutical companies and academic institutions to conduct more extensive glycomics studies in this region.

Major market player included in this report are:

• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Agilent Technologies Inc.
• Bruker
• New England Biolabs
• Shimadzu Corporation
• Waters Corporation
• Takara Bio Inc
• Asparia Glycomics
• RayBiotech Life, Inc.

Recent Developments in the Market:

• In September 2021, a team of researchers at the University of California San Diego created a new tool called GlyCompare which allows for the analysis of glycomics datasets using AI and other machine learning techniques. This approach takes into account the shared biosynthetic pathways of glycans in samples, making it a systems-level perception. The ultimate goal of this research is to contribute to the development of breakthroughs in cancer diagnostics.
• In April 2021, BridgeBio Pharma, Inc. and the Canadian Glycomics Network collaborated to translate scientific research in glycomics into potential treatments for patients having genetic diseases.

Global Glycomics Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Application, End-Use, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Enzymes
• Kits
• Reagents
• Instruments

By Application:

• Drug Discovery & Development
• Diagnostics
• Others

By End-Use:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Biopharmaceutical Companies
• CROs

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Glycomics Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Glycomics Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Glycomics Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Glycomics Market, by End-Use, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Glycomics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Glycomics Market Dynamics

• 3.1. Glycomics Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing interest in understanding the role of glycomics in disease profiling and biological processes
    • 3.1.1.2. Technological investment in glycomics instruments
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of the Tools
    • 3.1.2.2. Complexity of glycans
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising investments in research and development by companies and government
    • 3.1.3.2. Growing number of biotechnology and biopharmaceuticals industry

Chapter 4. Global Glycomics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Glycomics Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Glycomics Market by Product, Performance - Potential Analysis
• 5.3. Global Glycomics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Glycomics Market, Sub Segment Analysis
  • 5.4.1. Enzymes
  • 5.4.2. Kits
  • 5.4.3. Reagents
  • 5.4.4. Instruments

Chapter 6. Global Glycomics Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Glycomics Market by Application, Performance - Potential Analysis
• 6.3. Global Glycomics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Glycomics Market, Sub Segment Analysis
  • 6.4.1. Drug Discovery & Development
  • 6.4.2. Diagnostics
  • 6.4.3. Others

Chapter 7. Global Glycomics Market, by End-Use

• 7.1. Market Snapshot
• 7.2. Global Glycomics Market by End-Use, Performance - Potential Analysis
• 7.3. Global Glycomics Market Estimates & Forecasts by End-Use 2020-2030 (USD Billion)
• 7.4. Glycomics Market, Sub Segment Analysis
  • 7.4.1. Academic & Research Institutes
  • 7.4.2. Pharmaceutical & Biotechnology Companies
  • 7.4.3. Biopharmaceutical Companies
  • 7.4.4. CROs

Chapter 8. Global Glycomics Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Glycomics Market, Regional Market Snapshot
• 8.4. North America Glycomics Market
  • 8.4.1. U.S. Glycomics Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End-Use breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Glycomics Market
• 8.5. Europe Glycomics Market Snapshot
  • 8.5.1. U.K. Glycomics Market
  • 8.5.2. Germany Glycomics Market
  • 8.5.3. France Glycomics Market
  • 8.5.4. Spain Glycomics Market
  • 8.5.5. Italy Glycomics Market
  • 8.5.6. Rest of Europe Glycomics Market
• 8.6. Asia-Pacific Glycomics Market Snapshot
  • 8.6.1. China Glycomics Market
  • 8.6.2. India Glycomics Market
  • 8.6.3. Japan Glycomics Market
  • 8.6.4. Australia Glycomics Market
  • 8.6.5. South Korea Glycomics Market
  • 8.6.6. Rest of Asia Pacific Glycomics Market
• 8.7. Latin America Glycomics Market Snapshot
  • 8.7.1. Brazil Glycomics Market
  • 8.7.2. Mexico Glycomics Market
• 8.8. Middle East & Africa Glycomics Market
  • 8.8.1. Saudi Arabia Glycomics Market
  • 8.8.2. South Africa Glycomics Market
  • 8.8.3. Rest of Middle East & Africa Glycomics Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Thermo Fisher Scientific, Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Merck KgaA
  • 9.3.3. Agilent Technologies Inc.
  • 9.3.4. Bruker
  • 9.3.5. New England Biolabs
  • 9.3.6. Shimadzu Corporation
  • 9.3.7. Waters Corporation
  • 9.3.8. Takara Bio Inc
  • 9.3.9. Asparia Glycomics
  • 9.3.10. RayBiotech Life, Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption